Viz.ai is the leader in applied artificial intelligence in healthcare. It was inspired by a patient who underwent a successful brain surgery and yet died because the surgery came too late.
Viz.ai uses deep learning algorithms to identify a suspected large vessel occlusion - a disabling type of stroke - in a CT scan and alerts the stroke team specialist within minutes.
Viz.ai was founded in 2016 in Tel Aviv, Israel, by Chris Mansi, David Golan and Manoj Ramachandran. The company is headquartered in San Francisco, California, with an office in Tel Aviv, Israel.
Viz.ai’s mission is to fundamentally improve how healthcare is delivered in the world, through intelligent software that promises to reduce time to treatment and improve access to care.
Viz.ai’s flagship product, Viz LVO, leverages advanced deep learning to communicate time-sensitive information about suspected stroke patients straight to a specialist who can intervene and treat.
Viz.ai's Viz LVO system works with CT scanners from multiple manufacturers to automatically scan brain images for signs of stroke and notify neurovascular specialists using a mobile platform.
Viz.ai is backed by Kleiner Perkins, Greenoaks, GV, Scale Venture Partners, Insight Partners, Innovation Endeavors and others. The company raised $71M in a Serises C round on Mar 17, 2021. This brings Viz's total funding to $151.6M to date. Viz.ai was recognized in the inaugural Forbes AI list as one of America’s 50 Most Promising Artificial Intelligence Companies.